Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)
In this study, we attempt to target both the urokinase plasminogen activator and the mitogen-activated protein kinase pathway in acute myeloid leukemia (AML) cell lines and primary AML blasts using PrAgU2/LF, a urokinase-activated anthrax lethal toxin. PrAgU2/LF was cytotoxic to five out of nine AML...
Main Authors: | Amira Bekdash, Manal Darwish, Zahra Timsah, Elias Kassab, Hadi Ghanem, Vicky Najjar, Marwan Ghosn, Selim Nasser, Hiba El-Hajj, Ali Bazerbachi, Shihui Liu, Stephen H. Leppla, Arthur E. Frankel, Ralph J. Abi-Habib |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-10-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523315000571 |
Similar Items
-
The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.
by: Joppe W R Hovius, et al.
Published: (2009-05-01) -
Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
by: Bernard Degryse, et al.
Published: (2017-12-01) -
A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines
by: Reiser Jakob, et al.
Published: (2007-05-01) -
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
by: Bing-Tao Zhai, et al.
Published: (2022-03-01) -
E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
by: Shailza Sharma, et al.
Published: (2021-12-01)